FGF2 has been shown in preliminary animal studies to protect the heart from injury associated with a heart attack, reducing tissue death and promoting improved function after reperfusion.
O FGF2 demostrou en estudos preliminares en animais protexer o corazón de danos asociados cos ataques ao corazón, reducindo a morte tisular e promovendo unha mellora da función despois da reperfusión.